养殖肉品原料市场 - 全球与区域分析：分析与预测（2023-2028）

随着越来越多的消费者和食品公司寻求永续的替代蛋白质来源，培养肉原料市场正在改变食品产业。

培养肉类，也称为细胞培养肉或实验室培育肉，代表了食品产业的开创性发展。直接从动物细胞生产肉类为传统肉类生产提供了永续且合乎道德的替代方案。

随着世界寻求更永续的蛋白质选择，培养肉类成分提供了一个引人注目的解决方案。培养肉可以使用植物来源成分作为培养细胞的营养物质来生产，从而减少对传统畜牧业的依赖。藻类和微生物可用作培养肉类中具有成本效益且永续的营养来源。

细胞工程在肉类养殖中扮演重要角色。正在开发创新技术来有效分离和培养动物细胞，从而实现培养肉类的规模化生产。生物反应器对于创造完美的细胞生长环境和实现大规模肉类生产至关重要。

本报告考察了全球培养肉原料市场，并提供了市场概述、按产品、应用、地区分類的趋势以及进入市场的公司概况。

目录

第1章市场

• 产业展望
• 业务动态
• 市场策略与发展
• 商业机会
• 利害关係人分析
• 投资形势

第2章应用

• 养殖肉原料及设备市场－（依应用）
• 养殖肉原料及包装设备市场需求分析（依应用）

第3章产品

• 养殖肉原料及设备市场-（分产品）
• 养殖肉原料及设备市场需求分析（分产品）
• 供应链分析/价值链分析
• 专利分析

第4章区域

• 全球市场展望
• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第5章市场－竞争基准化分析与公司概况

• 竞争基准化分析
  • 竞争力矩阵
  • 市场占有率分析
• 公司简介
  • 原料生产商
  • 设备製造商

第6章调查方法

The Cultured Meat Ingredients Market is experiencing a transformative shift in the food industry, as an increasing number of consumers and food companies seek sustainable and alternative protein sources. This report provides a comprehensive analysis of the Cultured Meat Ingredients Market, focusing on alternate protein sources, cell engineering techniques, and the barriers in the commercialisation of cultivated meat.

Introduction

Cultivated meat, also known as cell-based meat or lab-grown meat, represents a pioneering development in the food industry. It offers a sustainable and ethical alternative to traditional meat production by producing meat directly from animal cells. This report explores the ingredients and technologies that make this innovation possible.

Market Overview

This report provides an overview of the Cultured Meat Ingredients Market, emphasizing its current state and growth prospects.

Market Size and Growth

• Factors driving this growth include increased consumer demand for sustainable and cruelty-free meat products, advancements in cell engineering, and the expanding food-tech industry.

Alternate Protein Sources

As the world seeks more sustainable protein options, cultivated meat ingredients offer a compelling solution.

• Plant-Based Proteins: Cultured meat can be produced using plant-based ingredients as a nutrient source for the cultivated cells, reducing the reliance on traditional livestock farming.

• Algae and Microbes: Algae and microorganisms can serve as a cost-effective and sustainable source of nutrients for cultivated meat, presenting opportunities for ingredient innovation.

Cell Engineering Techniques

Cell engineering plays a crucial role in the cultivation of meat.

• Cell Isolation and Proliferation: Innovative techniques are being developed to isolate and proliferate animal cells efficiently, ensuring the scalable production of cultivated meat.

• Bioreactors: Bioreactors are essential for creating the optimal environment for cell growth, enabling large-scale meat production.

Barriers in the Commercialization of Cultivated Meat

While cultivated meat holds promise, it faces significant challenges on its path to commercialization.

Regulatory Hurdles

• Labelling and Safety Standards: Regulations surrounding labelling, safety, and health standards for cultivated meat need to be established to ensure consumer trust and safety.

• Approval Processes: Streamlining regulatory approval processes is essential to enable the commercialization of cultivated meat products.

Cost and Scalability

• Cost-Effective Production: Reducing the cost of production is vital to make cultivated meat competitive with traditional meat products.

• Scaling Production: Scaling up production while maintaining quality and safety standards is a challenge that needs to be addressed.

Consumer Acceptance

• Cultural Acceptance: Consumer preferences and cultural acceptance of cultivated meat will be crucial for market success.

• Education and Awareness: Initiatives are needed to educate the public about the benefits of cultivated meat and dispel misconceptions.

Table of Contents

1. Markets

• 1.1. Industry Outlook
  • 1.1.1. Market Definition
  • 1.1.2. Alternate Protein Trends
    • 1.1.2.1. Alternate Protein: Current and Future
      • 1.1.2.1.1. Advantages of Alternate Protein in Large-Scale Manufacturing
      • 1.1.2.1.2. Disadvantages of Alternate Protein in Large-Scale Manufacturing
    • 1.1.2.2. Developments in Cell Engineering
    • 1.1.2.3. Exploration of Environmental Benefits of Alternate Protein
    • 1.1.2.4. Emerging Start-ups in the Sector
      • 1.1.2.4.1. Key Countries to Focus
      • 1.1.2.4.2. Research and Development Programs Supported by Governments and Investors
    • 1.1.2.5. Other Industrial Trends
      • 1.1.2.5.1. Hybrid Products
      • 1.1.2.5.2. Fast-Food and Restaurant Partnerships
      • 1.1.2.5.3. Cultured Dairy and Eggs
      • 1.1.2.5.4. Bioinformatics and Data-Driven Approaches
  • 1.1.3. Ecosystem / Ongoing Programs
    • 1.1.3.1. Consortiums and Associations
    • 1.1.3.2. Regulatory Landscape
    • 1.1.3.3. Government Initiatives
  • 1.1.4. Alternate Protein: Cost Analysis

(Note: This section talks about the costs comparison between plant-based, cultivated, and fermented meat alternatives)

• 1.2. Business Dynamics
  • 1.2.1. Business Drivers
  • 1.2.2. Barriers in the Commercialization of Cultivated Meat

(Note: This section covers the scientific/economical/cultural/regulatory barriers faced by Cultured Meat companies)

• 1.2.3. Market Strategies and Developments
  • 1.2.3.1. Business Strategies
    • 1.2.3.1.1. Product Developments
    • 1.2.3.1.2. Market Developments
  • 1.2.3.2. Corporate Strategies
    • 1.2.3.2.1. Mergers & Acquisitions
    • 1.2.3.2.2. Partnerships, Joint Ventures, Collaborations & Alliances
  • 1.2.3.3. Others
• 1.2.4. Business Opportunities

(Note: This segment consists of the analysis of the stakeholders in the Cultured Meat Ingredients and Equipment and equipment market. This will include equipment manufacturers such as Liberation Labs, ingredient manufacturers such as Matrix F.T., and others)

• 1.3. Stakeholder Analysis
• 1.4. Investment Landscape
  • 1.4.1. Key Investors
  • 1.4.2. Major Fundings

2. Application

• 2.1. Cultured Meat Ingredients and Equipment Market - (by Application)
  • 2.1.1. Cultured Meat Ingredients and Equipment Market, by End-User Industry
    • 2.1.1.1. Fermentation
    • 2.1.1.2. Other Alternate Meat Manufacturers
    • 2.1.1.3. Cell Engineering
    • 2.1.1.4. Others

(Note: These are tentative applications. Subject to change as per further research and analysis)

• 2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Application)
  • 2.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by End-User Industry

3. Products

• 3.1. Cultured Meat Ingredients and Equipment Market - (by Product)
  • 3.1.1. Cultured Meat Ingredients and Equipment Market, by Origin
    • 3.1.1.1. Animal-derived (such as Gelatin and Collagen)
    • 3.1.1.2. Plant-derived (such as Cellulose and Alginate)
    • 3.1.1.3. Synthetic (such as Synthetic Peptide Hydrogels)
  • 3.1.2. Cultured Meat Ingredients and Equipment Market, by Type of Starter Cells
    • 3.1.2.1. Skeletal Muscle Stem Cells
    • 3.1.2.2. Fibroblasts
    • 3.1.2.3. Embryonic Stem Cells
    • 3.1.2.4. Others (such as Adipose-Derived Cells, Mesenchymal Stem Cells, and Induced Pluripotent)
• 3.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Product)
  • 3.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Origin
  • 3.2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Type of Starter Cell
• 3.3. Supply Chain Analysis/Value Chain Analysis

(Note: The report will cover either the Supply Chain Analysis or Value Chain Analysis, depending upon data availability)

• 3.4. Patent Analysis

4. Region

• 4.1. Global Alternate Protein Outlook
• 4.2. North America
  • 4.2.1. North America (by Country)
    • 4.2.1.1. U.S.
    • 4.2.1.2. Canada
    • 4.2.1.3. Rest-of-North America
• 4.3. Europe
  • 4.3.1. Europe (by Country)
    • 4.3.1.1. Netherlands
    • 4.3.1.2. Israel
    • 4.3.1.3. Germany
    • 4.3.1.4. France
    • 4.3.1.5. Rest-of-Europe
• 4.4. U.K.
• 4.5. China
• 4.6. Asia-Pacific
  • 4.6.1. Asia-Pacific (by Country)
    • 4.6.1.1. Japan
    • 4.6.1.2. South Korea
    • 4.6.1.3. Singapore
    • 4.6.1.4. Rest-of-Asia-Pacific
• 4.7. Rest-of-the-World
  • 4.7.1. Rest-of-the-World (by Region)
    • 4.7.1.1. South America
    • 4.7.1.2. Middle East and Africa
      • 4.7.1.2.1. Israel

5. MARKETS -Competitive Benchmarking & Company Profiles

• 5.1. Competitive Benchmarking
  • 5.1.1. Competitive Position Matrix
  • 5.1.2. Market Share Analysis
    • 5.1.2.1. Ingredient Manufacturers
    • 5.1.2.2. Equipment Manufacturers
• 5.2. Company Profiles
  • 5.2.1. Ingredient Manufacturers
    • 5.2.1.1. AMSBIO
      • 5.2.1.1.1. Company Overview
      • 5.2.1.1.2. Product Portfolio
      • 5.2.1.1.3. Customer Profile
        • 5.2.1.1.3.1. Key Customers
        • 5.2.1.1.3.2. Target Customers
      • 5.2.1.1.4. Analyst View

Note: Similar Details will be provided for below mentioned companies.

• 5.2.1.2. Bright Biotech
• 5.2.1.3. BioBetter
• 5.2.1.4. Extracellular
• 5.2.1.5. IntegriCulture Inc.
• 5.2.1.6. Matrix F.T.
• 5.2.1.7. SeaWith Inc.
• 5.2.1.8. Sartorius AG
• 5.2.1.9. Multus Biotechnology

• 5.2.2. Equipment Manufacturers
  • 5.2.2.1. CELLULAR AGRICULTURE LTD
  • 5.2.2.2. Liberation Labs
  • 5.2.2.3. Prolific Machines

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
• 6.2. Data Triangulation
• 6.3. Market Estimation & Forecast
  • 6.3.1. Factors for Data Prediction and Modelling